Critical information sits scattered across disconnected databases. Analysis that should take hours stretches into weeks as ...

An agreement between the UK and the US will maintain tariffs on imports into the US at 0% but, as a quid pro quo, prices of ...

At the BIO-Europe congress in Vienna, the session titled “From Roasts to Billions: Biopharma Investment Landscape” brought ...

The EMA has started a review of a regimen based on Pfizer and Astellas' Padcev and MSD's Keytruda that has been described as ...

In the 104-patient, phase 3 trial, a daily oral dose of tinlarebant achieved the primary efficacy endpoint by demonstrating a ...

The five-year SURMOUNT-REAL UK trial, part of a collaboration signed last year between Lilly and the UK government, will ...

The source of the reports is an internal email to CBER staff in which Prasad said that, in a "profound revelation," the US ...

Prostate cancer screening should not be made available to the vast majority of men across the UK, according to a committee set up to recommend a screening policy for the health service.

The Clinical Data Research Report shows data managers are currently losing an estimated 12 hours per week per study to ...

In an ambitious move, Moderna has teamed up with OpenAI, the artificial intelligence company behind ChatGPT, to further integrate generative AI (GenAI) across its mRNA drug development and ...

Armed with positive phase 3 results with lead drug gedatolisib in breast cancer, Celcuity is preparing for an FDA filing and possible launch into what could be a blockbuster market. The results of the ...

GSK has marked the start of antimicrobial resistance (AMR) awareness week with the news that it will provide funding for six new research programmes and 50 scientific and academic roles in the UK. The ...